These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 20625355

  • 1. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW.
    Transplantation; 2010 Aug 27; 90(4):394-400. PubMed ID: 20625355
    [Abstract] [Full Text] [Related]

  • 2. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.
    Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN.
    Transplantation; 2014 Jul 15; 98(1):39-46. PubMed ID: 24646773
    [Abstract] [Full Text] [Related]

  • 3. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.
    Ho J, Wiebe C, Rush DN, Rigatto C, Storsley L, Karpinski M, Gao A, Gibson IW, Nickerson PW.
    Transplantation; 2013 Feb 27; 95(4):595-602. PubMed ID: 23192155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V.
    Transplantation; 2009 Feb 15; 87(3):436-44. PubMed ID: 19202451
    [Abstract] [Full Text] [Related]

  • 7. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.
    Transplantation; 2017 Jun 15; 101(6):1410-1415. PubMed ID: 27163535
    [Abstract] [Full Text] [Related]

  • 8. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
    Scherer A, Gwinner W, Mengel M, Kirsch T, Raulf F, Szustakowski JD, Hartmann N, Staedtler F, Engel G, Klupp J, Korn A, Kehren J, Haller H.
    Nephrol Dial Transplant; 2009 Aug 15; 24(8):2567-75. PubMed ID: 19398767
    [Abstract] [Full Text] [Related]

  • 9. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis.
    Schaub S, Nickerson P, Rush D, Mayr M, Hess C, Golian M, Stefura W, Hayglass K.
    Am J Transplant; 2009 Jun 15; 9(6):1347-53. PubMed ID: 19459809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M.
    Curr Opin Nephrol Hypertens; 2014 May 15; 23(3):245-50. PubMed ID: 24626060
    [Abstract] [Full Text] [Related]

  • 15. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E, Nicknam MH, Nafar M, Sharbafi MH, Keshavarz Shahbaz S, Barabadi M, Yekaninejad MS, Bahrami T, Ahmadpoor P, Amirzargar A.
    Iran J Allergy Asthma Immunol; 2015 Dec 15; 14(6):615-23. PubMed ID: 26725559
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C.
    Kidney Blood Press Res; 2016 Dec 15; 41(6):997-1007. PubMed ID: 27988512
    [Abstract] [Full Text] [Related]

  • 18. Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy.
    Akioka Y, Chikamoto H, Horita S, Yago R, Tanabe K, Yamaguchi Y, Hattori M.
    Clin Transplant; 2009 Aug 15; 23 Suppl 20():2-5. PubMed ID: 19594587
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies.
    Dantas M, Romão EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, Ravinal RC, Rodrigues Júnior AL, Coimbra TM.
    Kidney Blood Press Res; 2007 Aug 15; 30(5):306-13. PubMed ID: 17804911
    [Abstract] [Full Text] [Related]

  • 20. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.
    Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR.
    Am J Transplant; 2017 Mar 15; 17(3):712-723. PubMed ID: 27597148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.